Dec. 16 at 10:40 PM
$PRME ,
$ABCL and
$CTMX are my last stand pharma stocks. Wish Prime would get a voucher or something from the FDA for CGD, but if not maybe there's a new partnership. Without either catalyst the stock price goes down and I accumulate more. Abcellera stock price could go down because data read out for ABCL635 comes in 2h26, but they still generate revenue through partnerships that can expand - there could be a surprise. And CytomX is sitting on potentially good data read out for CX-2051 in 1h26. Plus they have several partner programs to keep the lights on. Trying to stay in cash for significant dips. Anything below
$3 is a gift for any of these stocks, namely Prime and Abcellera and there's a good chance to see that price action before potential life altering data arrives.
